Published on: 

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-10-09-2007, Volume 3, Issue 10

A roundup of manufacturing and service expansions.

Cambridge, MA (Sept. 18)Genzyme broke ground on an expansion of its flagship manufacturing facility at Allston Landing in Boston. The $150-million project is focused on adding space for manufacturing support functions and will allow for the creation of 90 jobs.


Somerset, NJ (Sept. 17)Catalent Pharma Solutions, a provider of outsourced clinical and commercial packaging services, will expand its temperature-controlled warehouse in Bolton, United Kingdom, to meet increased customer demand for clinical-supply services, especially cold-chain storage and distribution. This expansion involves a purpose-built extension of the existing facility and is expected to be operational in June 2008. Planned features for the temperature-controlled warehouse include floor space of more than 7500 ft2, more than 2700 controlled ambient storage locations, and a 320-pallet refrigerator.

St. Louis, MO (Sept. 12)—Sigma-Aldrich will invest in a site at the Wuxi-New District Park located northwest of Shanghai, China, for its new Asia-Pacific manufacturing hub. Sigma-Aldrich expects to initially invest $25 million to acquire land rights and construct its first phase, which includes a large-scale, non-CGMP, multipurpose organic manufacturing facility dedicated to supporting its SAFC fine chemicals business unit. Construction of the new plant is set to start by the end of 2007. When fully developed, the manufacturing plant is expected to produce raw materials, key intermediates, and final products in support of SAFC's businesses. The site will also contain analytical, packaging, and warehousing facilities.